What question did this study set out to answer?

Determine the functional role of osteopontin (OPN) in vascular calcification using a matrix Gla protein (MGP)-deficient mouse model.

October 14, 2002The Journal of Experimental MedicineOpen Access

Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice

View Full Paper

Ask AI

Bookmark

Authors

MSMei Y. SpeerUniversity of Washington MMMarc D. McKeeMcGill University RGRobert E. GuldbergGeorgia Institute of Technology

Discussion

Member takes

Implication

Genetic knockout mouse study reveals accelerated arterial calcification and early mortality in osteopontin-deficient mice, indicating osteopontin acts as an in vivo calcification inhibitor.

Key Points

Determine the functional role of osteopontin (OPN) in vascular calcification using a matrix Gla protein (MGP)-deficient mouse model.
Crossed OPN-deficient mutant mice with MGP-deficient mice to generate double-knockout models.
Quantified arterial mineral content (mmol/g dry weight), mapped cellular OPN expression against smooth muscle markers (SM alpha-actin, SM22alpha), and tracked survival.
Mice deficient in both MGP and OPN displayed 2-fold greater arterial calcification at 2 weeks and over 3-fold at 4 weeks compared to MGP(-/-) OPN(+/+) mice (which had 0.33 +/- 0.01 mmol/g dry weight at 2 weeks).
Double-deficient mice experienced significantly reduced survival times (4.4 +/- 0.2 weeks vs. 6.6 +/- 1.0 weeks in MGP(-/-) OPN(+/+) mice), dying from severe calcification-induced vascular rupture and hemorrhage.

Cite This Study

Speer et al. (2002) studied this question.

synapsesocial.com/papers/6a6fdaadce524a4339c3b047 https://doi.org/10.1084/jem.20020911

View Full Paper

Ask AI

Bookmark

Implication

Genetic knockout mouse study reveals accelerated arterial calcification and early mortality in osteopontin-deficient mice, indicating osteopontin acts as an in vivo calcification inhibitor.